Decreased Libido
Understanding Decreased Libido (Low Sexual Desire, Reduced Libido, Loss of Sexual Desire): Find clinical documentation resources and medical coding information for diagnosis 'D' related to decreased libido. Explore healthcare solutions for low sex drive and loss of sexual desire, including causes, diagnosis, and treatment options. This information is for healthcare professionals and medical coding purposes.
Reduced interest in sexual activity, causing distress.
Lack of sexual thoughts, fantasies, or initiation of intimacy.
Primary care, endocrinology, mental health clinics.
ICD-10 Code Families
Complete code families applicable to F52.0
When to use each related code
| Description | When to use |
|---|---|
| Reduced interest in sex. | Use for patients reporting low sexual desire impacting their well-being. Consider physiological and psychological factors. |
| Aversion to and avoidance of sexual contact. | For patients experiencing distress or anxiety related to sexual activity, consider past trauma or relationship issues. Code with specific phobia if applicable. |
| Inability to attain or maintain erection. | Specifically for males experiencing erectile dysfunction. Explore organic vs. psychological causes. Do not use for low desire. |
Best-practice checklist
- ✓Document onset, duration, and severity of Decreased Libido.
- ✓Include patient's reported symptoms related to Low Sexual Desire.
- ✓Note any contributing factors to Loss of Sexual Desire (medications, life stressors).
- ✓Record relevant medical history, including hormonal imbalances, mental health conditions.
- ✓Specify any treatments discussed/provided for Reduced Libido and patient response.
Common pitfalls to avoid
Coding D25.8 (other sexual dysfunction) without specificity when a more precise code exists (e.g., F52.0) for decreased libido risks inaccurate reporting and reduced reimbursement.
Failing to capture underlying medical conditions (depression, medications) contributing to decreased libido leads to incomplete clinical documentation and impacts quality metrics.
Coding decreased libido without sufficient clinical evidence, such as patient history or physical exam findings, increases audit risk and potential claim denials.
Best-practice tips
- 01Rule out underlying medical conditions (ICD-10: F52.2x, N94.89). Document specifics.
- 02Screen for hormonal imbalances, medications, and psychological factors. CDI: Detailed history.
- 03Lifestyle changes: exercise, stress reduction, sleep hygiene. Compliance: Patient education.
- 04Consider relationship counseling. Document communication and interaction dynamics.
- 05Explore FDA-approved therapies if indicated. Coding: Precise medication documentation.
Step-by-step checklist
- 1
Review patient history for medications impacting libido (e.g., SSRIs, antiandrogens).
- 2
Assess for hormonal imbalances (e.g., testosterone, estrogen, thyroid).
- 3
Screen for psychological factors (e.g., depression, anxiety, relationship issues).
- 4
Consider age-related decline and document age, gender, menopause status.
Ready-to-paste narrative
Patient presents with complaints of decreased libido, also described as low sexual desire or reduced libido, impacting their quality of life. Onset of symptoms is reported as [timeframe, e.g., gradual over the past six months, sudden following a specific event]. The patient denies any recent significant life stressors but acknowledges [relevant factors, e.g., increased work demands, relationship difficulties, new medications]. Review of systems is negative for symptoms suggestive of hypogonadism, thyroid dysfunction, or depression, though further evaluation may be warranted. Medical history includes [list relevant medical conditions, e.g., hypertension, diabetes] and current medications include [list current medications]. Sexual history reveals [relevant details, e.g., satisfying sexual relationship previously, history of sexual trauma, current relationship status]. Physical examination is unremarkable. Differential diagnosis includes hypoactive sexual desire disorder (HSDD), medication-induced sexual dysfunction, and psychological factors contributing to loss of sexual desire. Plan includes [diagnostic testing if indicated, e.g., hormone levels, thyroid function tests] and discussion of potential treatment options, including lifestyle modifications, counseling, and or pharmacological interventions for low libido management. Patient education provided regarding the multifactorial nature of sexual desire and the importance of addressing potential underlying medical or psychological factors. Follow-up scheduled in [timeframe] to reassess symptoms and adjust treatment plan as needed. ICD-10 code F52.0 (lack or loss of sexual libido) may be considered. Further evaluation and documentation will reflect ongoing assessment and response to treatment.
Common questions and answers
How can I differentiate between normal fluctuations in libido and clinically significant decreased libido (hypoactive sexual desire disorder or HSDD) in female patients?+
Differentiating between normal libido fluctuations and HSDD in female patients requires a thorough assessment considering various factors. Firstly, the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria for HSDD emphasize persistent or recurrently deficient (or absent) sexual/erotic thoughts or fantasies and desire for sexual activity, causing marked distress or interpersonal difficulty. It's crucial to distinguish HSDD from temporary dips in desire due to situational factors like stress, relationship issues, or medication side effects. Explore how the DSM-5 criteria can help in your diagnostic process and consider implementing standardized assessment tools like the Female Sexual Function Index (FSFI) to quantify desire and other aspects of sexual function. Furthermore, take a detailed history encompassing medical, psychological, and sociocultural factors influencing libido. Learn more about the impact of hormonal changes, chronic illnesses, and medications on female sexual desire to ensure accurate diagnosis and personalized treatment.
What are the most effective evidence-based treatment strategies for managing decreased libido (HSDD) related to antidepressant medication use in men?+
Managing antidepressant-induced HSDD in men often necessitates a multifaceted approach. While adjusting the antidepressant dosage or switching to an alternative medication with a lower risk of sexual side effects can be beneficial, this must be carefully balanced against the patient's mental health needs. Consider implementing strategies to mitigate the sexual side effects without compromising the antidepressant's efficacy. Evidence suggests that adding bupropion, a norepinephrine-dopamine reuptake inhibitor, or using PDE5 inhibitors like sildenafil can be effective in some cases. Explore how lifestyle modifications, such as regular exercise, stress reduction techniques, and improving sleep hygiene, can positively influence libido. Moreover, incorporating psychosexual therapy or couples counseling can help address psychological and relationship factors that may exacerbate the issue. Learn more about the latest research on emerging treatments for antidepressant-induced sexual dysfunction in men to stay updated on best practices.
What are the key diagnostic considerations and first-line treatment options for decreased libido in perimenopausal and postmenopausal women considering both hormonal and non-hormonal approaches?+
Decreased libido in perimenopausal and postmenopausal women requires a comprehensive evaluation considering the interplay of hormonal fluctuations, psychological factors, and age-related physiological changes. First-line treatment often involves addressing the underlying hormonal imbalance through hormone replacement therapy (HRT), which can improve vaginal dryness and atrophy, potentially increasing sexual comfort and desire. Explore how different HRT regimens and delivery methods (e.g., transdermal, oral) influence efficacy and safety profiles. Non-hormonal options include lubricants and moisturizers to address vaginal dryness, as well as ospemifene, a selective estrogen receptor modulator (SERM). Consider implementing lifestyle changes like regular exercise and stress management techniques to enhance overall well-being and potentially improve libido. Furthermore, if psychological factors like anxiety or depression contribute to decreased desire, cognitive behavioral therapy (CBT) or other psychological interventions may be beneficial. Learn more about the potential benefits and risks of testosterone therapy in postmenopausal women experiencing low libido, but always proceed with caution due to potential side effects.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.